1-(3-Chloro-4-fluoro-phenyl)-1H-naphtho[2,3-d][1,2,3]triazole-4,9-dione

ID: ALA4756155

Chembl Id: CHEMBL4756155

PubChem CID: 132938162

Max Phase: Preclinical

Molecular Formula: C16H7ClFN3O2

Molecular Weight: 327.70

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1c2ccccc2C(=O)c2c1nnn2-c1ccc(F)c(Cl)c1

Standard InChI:  InChI=1S/C16H7ClFN3O2/c17-11-7-8(5-6-12(11)18)21-14-13(19-20-21)15(22)9-3-1-2-4-10(9)16(14)23/h1-7H

Standard InChI Key:  ATRDTBIVIKQMFW-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4756155

    ---

Associated Targets(Human)

IDO1 Tchem Indoleamine 2,3-dioxygenase (6650 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TDO2 Tchem Tryptophan 2,3-dioxygenase (1554 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 327.70Molecular Weight (Monoisotopic): 327.0211AlogP: 2.84#Rotatable Bonds: 1
Polar Surface Area: 64.85Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.68CX LogD: 3.68
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.54Np Likeness Score: -1.58

References

1. Pan S,Zhou Y,Wang Q,Wang Y,Tian C,Wang T,Huang L,Nan J,Li L,Yang S.  (2020)  Discovery and structure-activity relationship studies of 1-aryl-1H-naphtho[2,3-d][1,2,3]triazole-4,9-dione derivatives as potent dual inhibitors of indoleamine 2,3-dioxygenase 1 (IDO1) and trytophan 2,3-dioxygenase (TDO).,  207  [PMID:32871341] [10.1016/j.ejmech.2020.112703]
2. Zhang Y, Hu Z, Zhang J, Ren C, Wang Y..  (2022)  Dual-target inhibitors of indoleamine 2, 3 dioxygenase 1 (Ido1): A promising direction in cancer immunotherapy.,  238  [PMID:35696861] [10.1016/j.ejmech.2022.114524]

Source